Lisa Osborne

CEO of Rana Healthcare Solutions, a boutique PR firm designed to meet the needs of newly-emerging and rapidly-evolving healthcare companies.

[Viz.ai @viz_ai]

We've been awarded a 2025 @EdisonAwards for the third consecutive year 💡 Viz HCM, our AI software solution, is designed to detect and triage patients with signs of hypertrophic cardiomyopathy (HCM). Read more 👉 https://t.co/xnvVjZ3Ehp

#EdisonAwards #AIinHealthcare #Innovation

[Viz.ai @viz_ai]

🙌 We are proud to announce that Viz HCM is a finalist in the New Brand Launch category for the 2024 @FiercePharma Marketing Awards. We are thrilled our brand campaign is receiving this prestigious recognition. https://t.co/BibTprRCm7

[Lisa Osborne @lisaoz]

CEO Geoff Gill will discuss how the #Verisense research-grade #SmartWatch, #DigitalHealthPanel & #DigitalBiobank can advance #brain research at 4 pm today @BU_Computing. More info: https://t.co/SHHUmYiMpr https://t.co/xAmFmrvqIc

[Lisa Osborne @lisaoz]

#Verisense CEO Geoff Gill is participating in a thought-provoking @BU_Computing panel discussion on #DataScience & #ArtificialIntelligence approaches to improve #brain health 4-6 pm ET Thurs. Addtl info: https://t.co/SHHUmYiMpr

[Lisa Osborne @lisaoz]

Verisense Health, a Shimmer Research Spin-off, Launches as a Digital Health Software and Data Management Company https://t.co/1naac7JYmk via @BioPharmaDive

[GenomeWeb @GenomeWeb]

BioIVT Acquires Biospecimen Firm Fidelis Research. Bulgaria-based Fidelis Research operates a network of 85 clinical biospecimen collection sites throughout Southeastern Europe. https://t.co/xkOWLXr6DZ

[Leland Teschler @DW_LeeTeschler]

Certara’s Simcyp COVID-19 Vaccine Model, a 2021 R&D 100 Awards winner https://t.co/1N1rBAh5zH

[Lisa Osborne @lisaoz]

R&D 100 winner of the day: Certara’s COVID-19 Vaccine Model https://t.co/YI4FhZ7jLf

[Lisa Osborne @lisaoz]

Congratulations @Certara for being named a finalist in the @EdisonAwards! Delighted to see your Simcyp COVID-19 Vaccine Model recognized.https://t.co/MP1smUIbhW #EdisonAwards #EA2022

[Lisa Osborne @lisaoz]

Ipsos, IVP Research Labs, Schlesinger Group to Employ Shimmer’s NeuroLynQ™ to Analyze Super Bowl Audience Reaction Live @MarTechSeries https://t.co/CND6xytQne

[Accumen Inc. @AccumenInc]

Dr. Aryeh Shander has joined Accumen's Medical Advisory Council as our newest medical director, where he will support our best-in-class comprehensive patient blood management programs. Read full release here! https://t.co/sBQUWbPvDh #PatientBloodManagement #MedTwitter #healthcare

[ShimmerSensing @ShimmerSensing]

Check out the More Than a Refresh podcast episode, where President of Shimmer Americas talks how #wearables can improve #healthcare, research, and #clinicaltrials!

[ASCPT Alexandria @ASCPT_ClinPharm]

Congratulations Piet van der Graaf who has been named the 2021 Leadership Award Recipient by the International Society of Pharmacometrics @ISOP1 !

[Accumen Inc. @AccumenInc]

#Healthcare has the highest number of attacks by ransomware than any other industry. What's causing this uptick in operational disruptions and how can Accumen’s partnership with @DiscoverAUI increase your organization’s resilience? #cyberattack
https://t.co/pAhkSgLFmZ

[Lab Bulletin @LabBulletin]

BioIVT Acquires Tissue Solutions Ltd., a UK-based Virtual Biobank https://t.co/rSdTQBqLpa

[Accumen Inc. @AccumenInc]

The utilization & cost of blood products is on the rise as hospitals manage high acuity patients & a shrinking blood donor pool associated with #COVID19 #blooddonation may be the 1st idea that comes to mind, but it's only 1 part of a multi-faceted approach https://t.co/xb9vnhTanX

[Lisa Osborne @lisaoz]

@ShimmerSensing adopts the V3 framework to validate its #Verisense® #wearable sensing platform for #clinicaltrials․ https://t.co/LchGVDbTiA https://t.co/sPIJmAFlDn

[Drug Discovery World @DDWJournal]

The challenge of providing rapid, effective protection against Covid-19

https://t.co/IojWe6zdje

#Covid19

[BioIVT @BioIVT]

This is the final day to join Dr. Raju Khatri at BioIVT as he talks about his research on the first human study on the impact of pregnancy hormones on multiple CYP proteins and the metabolism of nifedipine. Save your seat now! #drugdevelopment https://t.co/v5j37PSaP7

[ShimmerSensing @ShimmerSensing]

at #SCOPE2021, @ShimmerSensing's Geoff Gill discusses how #Verisense enables you to Meet all Endpoint Needs with a Single Platform. Join the talk today at 12:35pm EST in the Solutions Theatre